NCT00770172View on ClinicalTrials.gov

G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2011

Conditions
Chemotherapeutic Agent ToxicityNeutropeniaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

Given subcutaneously

Trial Locations (1)

14076

Centre Regional Francois Baclesse, Caen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER

NCT00770172 - G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy | Biotech Hunter | Biotech Hunter